CD8A and COVID-19: To this end, we longitudinally profiled Epstein-Barr virus (EBV)-specific and influenza A virus (IAV)-specific CD8+ T cells during acute COVID-19, 6 M and 12 M follow-up (Fig. 4a, and Supplementary Fig. 6a).